Dako, an Agilent Technologies Company, Announces FDA Approval of New Test for Lung Cancer Patients
October 12, 2015 02:06 ET
|
Dako Denmark A/S
GLOSTRUP, Denmark, Oct. 12, 2015 (GLOBE NEWSWIRE) -- Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, announced Oct. 9 that the U.S. Food and Drug Administration...
Dako, an Agilent Technologies Company, Announces FDA Approval of New Companion Diagnostic for Lung Cancer
October 05, 2015 02:05 ET
|
Dako Denmark A/S
GLOSTRUP, Denmark, Oct. 5, 2015 (GLOBE NEWSWIRE) -- Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, announced Oct. 2 that the U.S. Food and Drug Administration...
Dako, an Agilent Technologies Company, announces expanded collaboration with Amgen within companion diagnostics
March 24, 2015 09:10 ET
|
Dako Denmark A/S
GLOSTRUP, Denmark, March 24, 2015 (GLOBE NEWSWIRE) -- Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, today announced a new Master Collaboration Agreement with...
Dako, an Agilent Technologies company, and ONO PHARMACEUTICAL CO., LTD. announce collaboration on development of PD-L1 companion diagnostic test for investigational cancer drug Opdivo(R) (nivolumab)
February 16, 2015 02:07 ET
|
Dako Denmark A/S
GLOSTRUP, Denmark and OSAKA, Japan, Feb. 16, 2015 (GLOBE NEWSWIRE) -- Dako, an Agilent Technologies company ("Agilent") and a worldwide provider of cancer diagnostics, and ONO PHARMACEUTICAL CO., LTD....
Dako, an Agilent Technologies Company, and Cell Signaling Technology announce partnership within companion diagnostics
January 12, 2015 09:03 ET
|
Dako Denmark A/S
Glostrup, Denmark, Jan. 12, 2015 (GLOBE NEWSWIRE) -- Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics , and Cell Signaling Technology (CST), a worldwide provider of...
Dako Launches Fast HER2 ISH Assay for New Automated Staining Platform in Europe
September 01, 2014 09:12 ET
|
Dako Denmark A/S
GLOSTRUP, Denmark, Sept. 1, 2014 (GLOBE NEWSWIRE) -- Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics , today announced the EU launch of HER2 IQFISH pharmDx TM...
Dako Sponsors European Pathology Congress for Second Straight Year
August 29, 2014 09:07 ET
|
Dako Denmark A/S
GLOSTRUP, Denmark, Aug. 29, 2014 (GLOBE NEWSWIRE) -- Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, is again a major sponsor of the annual European Congress of...
Dako Sponsors Largest Histology Congress for 34th Year in a Row
August 25, 2014 09:09 ET
|
Dako Denmark A/S
GLOSTRUP, Denmark, Aug. 25, 2014 (GLOBE NEWSWIRE) -- Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, is a sponsor of this year's National Society for...
New White Paper by ProPath Supports Superiority of Dako's HER2 IQFISH pharmDx(TM) Kit
July 07, 2014 09:18 ET
|
Dako Denmark A/S
GLOSTRUP, Denmark, July 7, 2014 (GLOBE NEWSWIRE) -- Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics , today announced positive findings in a white paper by ProPath...
Dako, an Agilent Technologies Company, and U.S.-based Merck & Co. to collaborate on companion diagnostic test for analysis of tumor PD-L1 levels
May 30, 2014 09:07 ET
|
Dako Denmark A/S
GLOSTRUP, Denmark, May 30, 2014 (GLOBE NEWSWIRE) -- Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics , today announced a collaboration with Merck & Co., Inc. (...